Different experiences of two PRRT2-associated self-limited familial infantile epilepsy
Authors:
Open Access
- 3 April 2020
- journal article
- research article
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 120 (4) , 1025-1028
Abstract
To analyze the clinical characteristics and PRRT2 gene mutation of self-limited familial infantile epilepsy and evaluate the treatment responses of different antiepileptic drugs in self-limited familial infantile epilepsy. We reviewed the clinical feature and genetic mutation results and treatment responses of two sibling sisters. They were detected with the PRRT2 gene mutation through Sanger sequencing. Elder sister was treated with oxcarbazepine oral suspension, while younger sister was treated with levetiracetam oral solution. The two sibling sisters exhibited PRRT2 heterozygous mutation inherited from their mother in c.649dupC p.(Arg217fs). Oxcarbazepine oral suspension had an immediate effect on the elder sister who was treated with it. However, levetiracetam oral solution had no effect on younger sister even though the dose was increased, but she got seizure-free after turning to oxcarbazepine oral suspension. Oxcarbazepine, which plays the mechanism of the sodium channel blockers, has a more significant effect than levetiracetam, which has no mechanism of the sodium channel blockers in self-limited familial infantile epilepsy. The PRRT2 gene of infantile epileptic patients with a family history of infantile convulsions or paroxysmal kinesigenic dyskinesia(PKD) could be detected by sanger sequencing and a biomarker to select antiepileptic drugs which play the mechanism of the sodium channel blockers could be utilized.Keywords
Funding Information
- the international clinical technology exchange program for clinicians, at the province-level medical institutions of Zhejiang Province. (2015, Royal Free Hospital)
This publication has 16 references indexed in Scilit:
- PRRT2 mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraineNeurology, 2012
- The PRRT2 mutation c.649dupC is the so far most frequent cause of benign familial infantile convulsionsSeizure: European Journal of Epilepsy, 2012
- Oxcarbazepine Versus Carbamazepine in the Treatment of Paroxysmal Kinesigenic DyskinesiaInternational Journal of Neuroscience, 2012
- Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesiaNature Genetics, 2011
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- Familial Infantile Convulsions and Paroxysmal Choreoathetosis: A New Neurological Syndrome Linked to the Pericentromeric Region of Human Chromosome 16The American Journal of Human Genetics, 1997
- Benign partial epilepsy in infancy.Archives of Disease in Childhood, 1996
- Benign Partial Epilepsy with Secondarily Generalized Seizures in InfancyEpilepsia, 1993
- Benign infantile familial convulsionsEuropean Journal of Pediatrics, 1992
- Benign complex partial epilepsies in infancyPediatric Neurology, 1987